The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
Abstract In human gliomas, anti-tumor T cell responses are inhibited through induction of local and systemic immunosuppression. Immune checkpoint blockade is proving to be a success in several types of cancers. However, many studies reported that the treatment of glioblastoma patients with anti-CTLA...
Guardado en:
Autores principales: | Amina Ghouzlani, Abdelhakim Lakhdar, Soumaya Rafii, Mehdi Karkouri, Abdallah Badou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d63a8a9061749b18bfd3005525a1a84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
por: Qing Yuan, et al.
Publicado: (2021) -
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Katrin Aslan, et al.
Publicado: (2020) -
Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas
por: Kun Fan, et al.
Publicado: (2017) -
Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma
por: Wen Zhang, et al.
Publicado: (2021) -
Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Liguo Ye, et al.
Publicado: (2021)